<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>医药魔方 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-31T11:35:25+08:00</updated>
  <subtitle>世事洞明皆学问，人情练达即文章</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>达伯舒（信迪利单抗）患者救助项目启动！3.98万元封顶且门槛价低，患者可及性更高</title>
    <updated>2020-12-31T09:40:08+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-31:/s/UJVhi-fRhMn-f8-1_iXsfQ</id>
    <link href="https://mp.weixin.qq.com/s/UJVhi-fRhMn-f8-1_iXsfQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>晚期NSCLC抗血管生成药物治疗中国专家共识：2020 vs 2019对比</title>
    <updated>2020-12-31T09:40:08+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-31:/s/LkMjYVG_NzuayCHppNU4pQ</id>
    <link href="https://mp.weixin.qq.com/s/LkMjYVG_NzuayCHppNU4pQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>和黄医药「索凡替尼胶囊」获批上市</title>
    <updated>2020-12-31T09:40:08+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-31:/s/KzbEmAIDBEEwekb9h-B1VQ</id>
    <link href="https://mp.weixin.qq.com/s/KzbEmAIDBEEwekb9h-B1VQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2021年，这10家创新药公司有望在科创板上市</title>
    <updated>2020-12-30T07:44:02+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-30:/s/9v0742GtzD-e91ZlzvvCOg</id>
    <link href="https://mp.weixin.qq.com/s/9v0742GtzD-e91ZlzvvCOg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Science：解决耐药难题，这款来自海洋的抗真菌药有何奇效？</title>
    <updated>2020-12-30T07:44:02+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-30:/s/kKYyfhPtjgoFIADWghgBVA</id>
    <link href="https://mp.weixin.qq.com/s/kKYyfhPtjgoFIADWghgBVA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>信达生物战略升级</title>
    <updated>2020-12-30T07:44:02+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-30:/s/6MQ9WrqR1-RKtzThZ0wd3Q</id>
    <link href="https://mp.weixin.qq.com/s/6MQ9WrqR1-RKtzThZ0wd3Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>王进：我曾把临床试验带到了战火纷飞的格鲁吉亚</title>
    <updated>2020-12-29T08:20:38+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-29:/s/5HrNyCAiyHSKKl_2Vx2k0Q</id>
    <link href="https://mp.weixin.qq.com/s/5HrNyCAiyHSKKl_2Vx2k0Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>维迪西妥单抗获CDE突破性治疗认可，有望填补HER2阳性尿路上皮癌治疗空白</title>
    <updated>2020-12-29T08:20:38+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-29:/s/kFNAFnzeS-iP7_KG9N066A</id>
    <link href="https://mp.weixin.qq.com/s/kFNAFnzeS-iP7_KG9N066A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Nature里程碑：双管齐下的抗生素——IspH抑制剂</title>
    <updated>2020-12-29T08:20:38+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-29:/s/W9BGPwZE5DH5UGn7JiBNsQ</id>
    <link href="https://mp.weixin.qq.com/s/W9BGPwZE5DH5UGn7JiBNsQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>吉利德科学再交完美答卷，“抗病毒传奇”只为“治愈”而生</title>
    <updated>2020-12-28T07:47:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-28:/s/MpoU2VaWXjrfgVNNwbsPQQ</id>
    <link href="https://mp.weixin.qq.com/s/MpoU2VaWXjrfgVNNwbsPQQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>抗癌靶点XPO1「图鉴」</title>
    <updated>2020-12-28T07:47:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-28:/s/DWmuJfzDEFOSb7DeToELbQ</id>
    <link href="https://mp.weixin.qq.com/s/DWmuJfzDEFOSb7DeToELbQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>大咖齐聚新年煮酒论医药！丨BIO APAC 2021，1月20-21日上海</title>
    <updated>2020-12-28T07:47:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-28:/s/4HK8IEh_81P-Nbi0NO6fnA</id>
    <link href="https://mp.weixin.qq.com/s/4HK8IEh_81P-Nbi0NO6fnA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020年具有里程碑意义的临床研究TOP10</title>
    <updated>2020-12-27T09:05:12+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-27:/s/vQxvEqGCtxG0Xp2wgazIfQ</id>
    <link href="https://mp.weixin.qq.com/s/vQxvEqGCtxG0Xp2wgazIfQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>盘点：2020年FDA批准的新药</title>
    <updated>2020-12-26T08:04:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-26:/s/6XktfitduxoIuXzlCz-TSA</id>
    <link href="https://mp.weixin.qq.com/s/6XktfitduxoIuXzlCz-TSA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020年失败临床研究TOP10</title>
    <updated>2020-12-25T07:45:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-25:/s/JWQemuZysEADTgqJ7pu5oQ</id>
    <link href="https://mp.weixin.qq.com/s/JWQemuZysEADTgqJ7pu5oQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Nature最新报告：外泌体疗法，迈向临床</title>
    <updated>2020-12-25T07:45:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-25:/s/CsTkb7ZDDXD5Dd8753Bwdw</id>
    <link href="https://mp.weixin.qq.com/s/CsTkb7ZDDXD5Dd8753Bwdw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>PARP抑制剂在晚期乳腺癌的OS获益：真实还是泡影？</title>
    <updated>2020-12-25T07:45:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-25:/s/FrvPofnw66Y-yykqyGCB1Q</id>
    <link href="https://mp.weixin.qq.com/s/FrvPofnw66Y-yykqyGCB1Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>极目生物获得国内首个治疗UME临床试验批件! 脉络膜上腔给药注射给患者带来更多福音</title>
    <updated>2020-12-25T07:45:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-25:/s/bNI4-KTY97_d2dgQpTu2kg</id>
    <link href="https://mp.weixin.qq.com/s/bNI4-KTY97_d2dgQpTu2kg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>DS-8201获CDE拟突破性疗法认定， 治疗胃癌或食管胃结合部腺癌</title>
    <updated>2020-12-24T07:53:49+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-24:/s/IeVXwgSDPbp0bYfYMPfjig</id>
    <link href="https://mp.weixin.qq.com/s/IeVXwgSDPbp0bYfYMPfjig" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>姜宝红点评 | Nature：心血管疾病诊断和治疗新靶点——ALDH4A1</title>
    <updated>2020-12-24T07:53:49+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-24:/s/tc3e7IOW7GmR7qztmyLeLQ</id>
    <link href="https://mp.weixin.qq.com/s/tc3e7IOW7GmR7qztmyLeLQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>